气相色谱质谱法快速测定人血浆中克仑特罗

血浆样品经0.01mol·L-1盐酸和无水乙醇浸取,在碱性条件下用氯仿萃取,GG-MS-选择离子测量法测定,外标法定量。在选定的色谱条件下,盐酸克仑特罗的检出限为0.05ng,线性范围为0.1-100ng,方法的平均回收率为95.6％,RSD小于6.82％(n=6)。该法毋需衍生化,基质无干扰,简便可靠,适用于生物材料中克仑特罗的快速分析。     

用铍试剂测定人血清白蛋白的分光光度法

在pH3.6的缓冲溶液中，铍试剂Ⅲ与人血清白蛋白（HSA）能形成复合物，吸光度与HSA的含量呈线性关系；复合物的最大吸收峰波长λmax=460nm,比铍试剂本身紫移80nm左右；HSA标准曲线线性范围为20－140mg/L；实验表明该反应选择性、重复性很好，操作简便，适用测定含量范围宽，测定结果与传统的考马斯亮蓝法结果相吻合。     

Analysis of selected pesticides and alkylphenols in human cord blood by gas chromatograph-mass spectrometer

A total of seven pesticides and eight alkylphenols were monitored using this method for the determination of their trace levels in human cord blood. The pesticides are lindane, diazinon, α-endosulfan, β-endosulfan, endosulfan sulfate, chlorpyrifos and endrin; while the alkylphenols are 4-n-butylphenol, 4-n-pentylphenol, 4-n-hexylphenol, 4-t-octylphenol, 4-n-heptylphenol, nonylphenol, 4-n-octylphenol and bisphenol A. The pesticides and alkylphenols in the cord blood samples were extracted with solid phase extraction IST C18 cartridges and analyzed by selected ion monitoring mode using quadrapole detector in Shimadzu QP-5000 gas chromatograph-mass spectrometer. Trace levels of pesticide and alkylphenols in the range of non-detectable to 15.17 ng ml⁻¹, were detected in the human cord blood samples. This technique of monitoring the levels of endocrine-disruptors in blood samples is consistent, reliable and cost effective while reducing wastage of time and solvents.     

应用单细胞微凝胶电泳技术研究氯化镉对人血淋巴细胞DNA的损伤效应

详细介绍了单细胞微凝胶电泳（ＳＣＧ）技术的原理和操作过程，并应用该技术研究了氯化镉（ＣｄＣｌ２）对人血淋巴细胞ＤＮＡ的损伤效应，结果表明，ＣｄＣｌ２能引起细胞ＤＮＡ迁移长度增加，且呈显著的剂量效应关系，对未处理对照细胞的ＤＮＡ迁移的原因及ＳＣＧ实验操作过程中应注意的事项也进行了讨论。     

On-line SFE-GC for determination of PCBs in human milk and blood serum

On-line coupled supercritical fluid extraction and gas chromatography (SFE-GC) has been utilized for the determination of PCBs and other organochlorine compounds in human milk and blood serum. The procedure involved preconcentration of the sample on C₁₈-silica sorbent in an extraction cell: after precipitation of the proteins up to 20 ml of human milk was concentrated on 0.5 g of sorbent. Serum (up to 5 ml) was applied to the C₁₈ material without pretreatment. Basic alumina was utilized as a selective adsorbent for lipids in the on-line SFE-GC system. The method was used to analyze milk and serum spiked with 0.5 and 10 ng of Aroclor 1260 and the results compared with those obtained by liquid–liquid extraction of serum.     

Using a new solvation model for thermodynamic study on the interaction of nickel with human growth hormone

Thermodynamics of the interaction between Ni²⁺ and human growth hormone (hGH) were determined at 27 °C in Nail solution by isothermal titration calorimetry. A new method to predict protein penetration and the effect of metal ions on the stability of proteins is introduced. The new solvation model was used to reproduce the enthalpies of Ni²⁺-hGH interaction over the whole range of Ni²⁺ concentrations. The solvation parameters recovered from the new equation, attributed to the structural change of hGH and its biological activity.     

Simultaneous determination of 11 drugs belonging to four different groups in human urine samples by reversed-phase high-performance liquid chromatography method

A new, accurate, sensitive and fast reversed-phase high-performance liquid chromatography (RP-HPLC) as an analytical method for the quantitative determination of 11 drugs in human urine was worked out, optimized and validated. The objects of analysis were imipenem (IMP), paracetamol (PAR), dipyrone (DPR), vancomycin (VCM), amikacin (AMK), fluconazole (FZ), cefazolin (CFZ), prednisolone (PRE), dexamethasone (DEX), furosemide (FUR) and ketoprofen (KET) belonging to four different groups (antibiotics, analgesic, demulcent and diuretic). For HPLC analysis, diode array (DAD) and fluorescence (FL) detectors were used. The separation of analyzed compounds was conducted by means of a LiChroCART^® Purospher^® C₁₈e (125 mm × 3 mm, particle size 5 μm) analytical column with LiChroCART^® LiChrospher^® C₁₈ (4 mm × 4 mm, particle size 5 μm) pre-column with gradient elution. Analyzed drugs were determined within 20 min. The mobile phase was comprised of various proportions of methanol, acetonitrile and 0.05% trifluoroacetic acid in water. AMK was separated and determined from human urine using ortho-phthaldialdehyde-3-mercaptopropionic acid (OPA-3-MPA) as a fluorescent reagent by RP-HPLC-FL. The following retention times for drugs IMP, PAR, DPR, VCM, AMK, FZ, CFZ, PRE, DEX, FUR and KET in human urine were found: 4.01 min, 4.86 min, 6.71 min, 8.14 min, 9.46 min, 10.01 min, 10.90 min, 13.34 min, 14.06 min, 16.03 min and 18.98 min, respectively. Excellent linearity was obtained for compounds in the range of concentration: 0.35-42 μg ml⁻¹, 0.5-45 μg ml⁻¹, 4.5-38 μg ml⁻¹, 0.25-25 μg ml⁻¹, 0.5-35 μg ml⁻¹, 0.25-22 μg ml⁻¹, 0.03-52 μg ml⁻¹, 0.15-25 μg ml⁻¹, 0.25-28 μg ml⁻¹, 0.05-18 μg ml⁻¹ and 0.15-35 μg ml⁻¹ for IMP, PAR, DPR, VCM, AMK, FZ, CFZ, PRE, DEX, FUR and KET, respectively. The limits of detection (LOD) and limits of quantification (LOQ) for analyzed drugs were calculated in all cases and recovery studies were also performed. Ten human urine samples obtained from patients treated in hospital have been tested. In analyzed samples, one or more drugs from the 11 examined drugs were detected. The concentrations of examined drugs in urine samples ranged between: 1.5-12 μg ml⁻¹ of PAR, 5.2-11.5 μg ml⁻¹ of DPR, 0.13-9.5 μg ml⁻¹ of CFZ and 0.1-8 μg ml⁻¹ of FUR. This method can be successfully applied to routine determination of all these drugs in human urine samples.     

Determination of selenium in human milk by electrothermal atomic absorption spectrometry and chemical modification

A method was developed for the determination of selenium in human milk using electrothermal atomic absorption spectrometry. The use of chemical modifiers as well as their implications during the pyrolysis step was examined. The chemical modifiers that were studied were Zr, Ir as well as the mixed modifier Zr-Ir. The Ir modifier stabilized selenium at 1000 °C, Zr at 800 °C, while the mixed modifier at 1200 °C. The effect of modifier mass was studied and was found that better results are achieved with addition of 2 μg Zr and 2 μg Ir. The characteristic masses of selenium in the presence of Zr, Ir and the mixed modifier were found to be 73.3, 18.0 and 14.7 pg, respectively, while the corresponding limits of detection were found 2.0, 0.50 and 0.41 μg l⁻¹. Consequently better results were obtained with the mixed modifier. The developed method was applied for the determination of selenium in human milk, which was digested with a HNO₃ + H₂O₂ mixture in a microwave oven. The limit of detection of the method was 1.37 μg l⁻¹, the characteristic mass, m₀, was 48.8 pg and the repeatability was less than 5% as R.S.D.(%). Matrix matched calibration was used. Recoveries were estimated to be 93-105%. The method was applied to breast milk of Greek women (n = 9) and the Se content was found to be in the range 16.7-42.6 μg l⁻¹ with mean value 27.4 ± 5.5 μg l⁻¹.     

Determination of physiological noble metals in human urine using liquid-liquid extraction and Zeeman electrothermal atomic absorption spectrometry

An extremely sensitive, reliable and simple procedure is described for the determination of physiological palladium, platinum and gold in human urine. The urine samples were adjusted to pH 4 (Pd, Au) or pH 5 (Pt), followed by conversion of the analytes to their pyrrolidinedithiocarbamate complexes. These complexes were separated from the matrix by liquid-liquid extraction into 4-methyl-2-pentanone resulting in a 25-fold enrichment. Determination was by electrothermal atomic absorption spectrometry (ET-AAS) using longitudinal inverse alternating current Zeeman-effect background correction. The limits of detection calculated from three standard deviations of the blank values were 20 ng l⁻¹ for Pd and Au and 70 ng l⁻¹ Pt. Within-day precision (n = 10, 5 μg l⁻¹) ranged 5.2%–7.7%. The procedure is successfully applied to determine urinary palladium, platinum and gold in nine unexposed persons. Palladium levels in urine ranged < 20–80 ng l⁻¹ (arithmetical MEAN=38.7 ng l⁻¹), while gold levels ranged < 20–130 ng l⁻¹ (36.0 ng l⁻¹). Physiological platinum levels in urine were all < 70 ng l⁻¹. The accuracy of the procedure was checked by analyzing a series of urine samples by a second independent method (magnetic sector field inductively-coupled plasma-mass spectrometry) in combination with UV photolysis.